The global neuroprosthetics market comprises medical devices that are commonly known as brain-computer interfaces or neural prosthetics. These devices help in restoring lost neural functions to treat various medical conditions associated with the nervous system like Parkinson’s disease, epilepsy, spinal cord injury, dystonia, and tremor. Neuroprosthetic devices use electrical or optical signals introduced into the body to assist, replace, or enhance neural functions. Key product types include deep brain stimulation (DBS), vagus nerve stimulation (VNS), spinal cord stimulation (SCS), and cochlear implants.
The Global Neuroprosthetics Market Share is estimated to be valued at US$ 12.66 BN in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031. Key benefits offered by neuroprosthetics include restoring motor functions, vision, hearing, regulating abnormal brain activity, reducing tremors, and improving mobility. Rising prevalence of neurological disorders and increasing investments in brain-computer interface technology development are fueling market growth.
Key Takeaways
Key players operating in the global neuroprosthetics market are Second Sight, Med-El, Retina Implant, Sonova Holding AG. , NeuroPace, Inc., Nevro, Medtronic plc, Abbott, Cochlear, Boston Scientific Corporation, Livanova, Demant A/S, Cyberonics Inc. and NDI Medical LLC. Major players are investing in R&D to introduce technologically advanced products and expand their geographic footprint across developed and emerging markets.
Rising geriatric population suffering from neurological conditions like Parkinson’s disease and Alzheimer’s has increased the demand for effective treatment solutions. Neuroprosthetics provide an improved quality of life to patients with minimal side effects.
Key players are focusing on developing next-generation neural devices that can be wirelessly controlled through external devices. This is enabling greater geographic expansion as complex surgical procedures can be avoided. Companies are also incorporating new materials and using biocompatible substrates to develop seamlessly integrating brain implants.
Market drivers
The rapid technological advancements in brain-computer interface technologies is a key driver for the neuroprosthetics market growth. Continuous funding from government bodies and private investors has enabled major leaps in developing advanced brain monitoring and signal processing capabilities. This has made neural implants smaller, more effective, biocompatible and compatible with the latest portable computing platforms. Miniaturized prosthetics can now restore finer motor controls and complex neuron signaling patterns.
Current geopolitical situations like the Russia-Ukraine war and the ongoing tensions between the US and China are impacting the global Neuroprosthetics market growth. The restrictions on exports from warring nations to other countries have disrupted supply chains. This has caused delays in delivery of critical components and raw materials used in Neuroprosthetics manufacturing. Additionally, economic downturns in many parts of the world due to higher inflation and food/energy crises have reduced discretionary spending on non-essential medical devices and treatments. Many patients are postponing neuroprosthetic procedures. To counter these challenges, companies must look for new suppliers in different countries, build up buffer inventories, and offer deferred payment options or insurance tie-ups to boost affordability for customers. Over the long run, as geopolitical stability returns, focus on emerging markets will be key to sustaining high growth rates for the Neuroprosthetics industry.
The North American region currently accounts for the largest share of the global Neuroprosthetics market in terms of value. This is due to factors like the large target patient population, growing acceptance of technologically advanced neuroprosthetic solutions, and favorable reimbursement policies supporting medical device development in the U.S. and Canada. Europe is another major regional market concentrated mainly Western nations with strong per capita spending on healthcare. The Asia Pacific region excluding Japan & China is projected to grow at the fastest rate during the forecast period for the Neuroprosthetics market. This can be attributed to rising medical standards, growing investment by Neuroprosthetic players, and increasing preference for minimally invasive procedures in high potential developing countries.
The Asia Pacific region excluding Japan and China currently represents the fastest growing geographical area for the global Neuroprosthetics market. Nations like India, South Korea, Australia and various Southeast Asian countries are experiencing rapid economic development and improved access to advanced healthcare technologies. With a large untapped patient pool and investment in medical infrastructure & services, the volume growth potential for Neuroproprosthetic devices is immense. Additionally, the presence of a young demographic profile makes Asia Pacific an attractive region for early adoption of latest treatment innovations. Neuroprosthetic companies need to focus on regional market needs through innovative and affordable product offerings to leverage expanding opportunities.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it